OnabotulinumtoxinA Successfully Used as Migraine Prophylaxis During Pregnancy: A Case Report
Clicks: 117
ID: 261195
2014
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
1.2
/100
4 views
4 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
ABSTRACT. Botulinum toxin (btx) received U.S. Food and Drug Administration approval for migraine treatment in 2010 with a pregnancy category C. There are minim
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (24 words).
Try re-searching for a better abstract.
| Reference Key |
y.2014militaryonabotulinumtoxina
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Robinson, Andrew Y.;Grogan, Patrick M.; |
| Journal | Military Medicine |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
pregnancy
adult
female
case reports
Infant
newborn
pregnancy complications / prevention & control*
botulinum toxins
type a / therapeutic use*
pmid:24902141
doi:10.7205/milmed-d-13-00477
andrew y robinson
patrick m grogan
acetylcholine release inhibitors / therapeutic use*
apgar score
migraine disorders / prevention & control*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.